Entera Bio
ENTX
Entera Bio (ENTX) news
Recent news
EnterA Bio placement led by existing investor BVE Partners
AInvest Wire · Jul 27, 2026EnterA Bio says proceeds to extend cash runway into 2030
AInvest Wire · Jul 27, 2026EnterA Bio announces pricing of oversubscribed $275M placement
Entera Bio Inc. has announced the pricing of an oversubscribed equity placement, raising $275 million in gross proceeds. The offering, which exceeded initial expectations, reflects strong investor confidence in the company’s pipeline and strategic direction. The funds will be allocated toward…
AInvest Wire · Jul 27, 2026EnterA Bio - expects to submit NDA for EB613 based on 12-month data; 24-month extension study planned
AInvest Wire · Jun 22, 2026EnterA Bio - Phase 3 initiation planned for late 2026; top-line data expected in second half of 2028
AInvest Wire · Jun 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.